News | January 18, 2024
NATCO invests US$ 2 million in Cellogen Therapeutics
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Both the India and GCC entities will be operated by separate dedicated management teams
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
US business grew by +12.8% YoY
Subscribe To Our Newsletter & Stay Updated
